Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA synthesis is a fundamental process during the cell cycle, specifically occurring in the S-phase, where a cell duplicates its entire genome before division. In tumor cells, this process is often dysregulated, leading to uncontrolled proliferation and genetic instability. Targeting aberrant DNA synthesis has become an important strategy for cancer therapy. Many chemotherapeutic agents disrupt nucleotide metabolism or directly inhibit enzymes involved in replication. Novel therapies aim at exploiting unique vulnerabilities of tumor cell replication machinery, which may selectively affect rapidly dividing tumor cells while sparing normal tissue.
Inhibition of DNA replication enzymes (e.g., DNA polymerases, helicases), disruption of nucleotide metabolism, induction of replication stress and DNA damage.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Synthesis in Dividing Tumor Cells (N/A).